Upcoming Medical Conferences in Brussels

Palliative Care and Radiotherapy - A Course on Prognosis, Symptom Control, Re-Irradiation and Oligometastases is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Nov 26 - 28, 2019 at ESTRO Office, Brussels, Belgium. Target Group : This basic course is aimed primarily at trainee radiation and medical oncologists and experienced radiation and medical oncologists who want an update of their clinical knowledge. Clinical physicists, palliative care physicians and specialist nurses are welcome to participate. Description : In this course, a comprehensive overview of the applicability and effectiveness of palliative radiotherapy schedules from an evidence based perspective will be provided in a multidisciplinary framework. Focus will be on both clinical-ethical aspects and more technical-physics related issues. Learning outcomes : By the end of this course participants should  • Have knowledge of the principles of palliation, pain management, and indications for and effectiveness of palliative radiotherapy schedules • Be able to discuss clinical cases on management, expected survival, clinical outcome in terms of quality of life and side effects using evidence based outcome tools. Course Content : • Principles of palliation, oligometastasis • Nature of cancer pain, physiology of pain • Principles of pharmacological management • Radiotherapy for pain: bone pain, soft tissue pain • Holistic pain therapy: integration of RT/CT/pharmacology and non-pharmacological approaches • Neurological complications: brain metastases - introduction and pharmacological management • Management of solitary brain metastases Management of multiple brain metastases • Malignant spinal metastasis, pathophysiology, diagnosis and initial management • Management of malignant spinal canal compression • Other neurological complications: spinal nerve root compression and neuropathic pain management • Care of the dying: different models of care • Lung - NSCLC: palliative management • Oligometastases and ablative therapy • Liver: role of radiotherapy in palliation • Palliative brachytherapy • Practical application of research data in palliation. Prerequisites : Before commencing this course you should have a basic understanding of radiotherapy and pharmacology and experience of caring for patients with advanced cancer. Additional details will be posted as soon as they are available.

Multidisciplinary Management of Brain Tumours is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Dec 01 - 03, 2019 at ESTRO Office, Brussels, Belgium. Target Group : The course is primarily aimed at specialists and trainees in the field of clinical/radiation oncology interested in extending their knowledge of the multidisciplinary management of central nervous system tumours. Other specialists with interest in brain tumours who wish to have an update on brain tumour treatment approaches with a particular focus on modern radiotherapy will also be most welcome. Description : The course aims to review the present state-of-the-art of neuro-oncology from its biological understanding to the implementation of high-tech radiotherapy approaches, modern biologically driven therapy and care. It will not only cover the commonest of brain tumours, but will also review the latest developments in the less common tumours in adults and children. Learning outcomes : By the end of this course participants should be able to: • Understand the evolving concepts of brain tumour biology • Interpret more complex brain imaging for the purpose of therapy • Make judgements regarding multidisciplinary management of tumours including the role of systemic and targeted therapies in both common and rare brain tumours in adults and children • Understand the principles and practice of modern radiotherapy • Understand the design and challenges of brain tumour clinical trials. Course Content : Neuro-oncology is generally equated with the management of malignant gliomas, yet it is the speciality with perhaps the largest range of tumour types from curable to barely treatable. It has been at the forefront of technical developments in radiotherapy with early implementation of the latest imaging and high precision localised radiotherapy, including stereotactic radiotherapy and proton therapy. Neurosurgery has also developed in leaps and bounds so that previously inaccessible locations can now be safely reached. Local treatment relies on accurate imaging and this is the cornerstone of neuro-oncology practice. Alongside local treatment approaches, systemic treatment has become mainstay of management of many tumours in adults and children and targeted personalised therapy approaches are becoming a reality. The need for developing and testing new therapies in this challenging clinical setting requires the involvement of neuro-oncology specialists in clinical trials and the issues specific to brain tumour trial design are of importance to the future of the speciality. Anyone involved in neuro-oncology is aware of the challenges in treating the brain and the short and long term consequences for the patient and their carers, and that attention to care is an integral part of neuro-oncology. Prerequisites : Before commencing this course you should have some: • Experience of brain tumour management • Understanding of conventional brain radiotherapy issues. Additional details will be posted as soon as they are available.

European Academy of Paediatrics (EAP) Winter Meeting 2019 is organized by European Academy of Paediatrics (EAP) and will be held from Dec 06 - 07, 2019 at Hilton Brussels Grand Place, Brussels, Brussel, Belgium. Description: The European Academy of Paediatrics (EAP) continues to promote child health and to harmonize standards of paediatric training and services throughout Europe. This meeting is a platform for all our National delegates and other members to discover new knowledge, to promote research and ensure their continuing professional development. Additional details will be posted as soon as information is available.

Annual Congress of the Belgian Society of Internal Medicine is organized by Belgian Society of Internal Medicine (BSIM) and will be held from Dec 13 - 14, 2019 at Dolce La Hulpe Brussels, Brussels, Belgium. Additional details will be posted as soon as they are available.

Echocardiography for Hemodynamic Monitoring 2019 is organized by International Symposium on Intensive Care and Emergency Medicine (ISICEM) and will be held from Nov 19 - 21, 2019 at Hospital Erasme, Brussels, Belgium.  Aim: To promote the use of echocardiography in the hemodynamic evaluation of critically ill patients. General description: The course, will be interactive, with a lot of time devoted to questions, hands-on sessions, and discussions of live video-transmissions. From this year, the course will be split into two sections: beginners (no or minimal clinical experience with echo) and advanced (have previously attended an echo course and have at least 1-year’s practical echo experience). On the first day, we will review some of the basics of echocardiography for our beginners and cover some more complex topics for our advanced group. The second and third days will describe how to use this technique to evaluate the hemodynam Additional details will be posted as soon as information is available.

Evaluation of ADMET Drug Properties in Drug Discovery and Development is organized by Mondial Research Group and will be held form Jan 21 - 22, 2020 at Brussels, Belgium. Additional details will be posted as soon as information is available.

14th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies is organized by Mondial Research Group and will be held from Jan 23 - 24, 2020 at Brussels, Belgium. Additional details will be posted as soon as information is available.

The 39th Belgian Society of Cardiology (BSC) Annual Congress is organized by Belgian Society of Cardiology (BSC) and will be held from Feb 13 - 14, 2020 at Brussels Expo - Exhibition Center, Brussels, Belgium. Additional Details will be posted as soon as they are available.

European Drug Discovery Conference is organized by Mondial Research Group and will be held from Feb 20 - 21, 2020 at Brussels, Belgium. Who should attend: Senior level directors, managers and scientists in drug discovery, preclinical development, ADME, DMPK, pharmokinetics, drug metabolism, toxicology, computational chemistry, molecular modeling, cheminformatics, drug design, biomolecular screening, physical chemistry, medicinal chemistry, lead optimization. Senior Executives, Heads and VP's of Applied Research, Applied Biology, Bioinformatics, Biology, Chemistry, Medical Affairs, Pre-Clinical Development, R&D, Regulatory Affairs, Scientific Affairs. Description: European Drug Discovery promises to be a gateway for collaboration and long term business advancement for all biotech and pharmaceutical companies doing business in Europe. With the latest "hot topics" and most recent developments in drug discovery technology being presented from some of the industries leading experts, coupled with numerous networking opportunities, this is an event you will not want to miss. Additional details will be posted as soon as information is available.

DIA Europe 2020 is organized by Drug Information Association (DIA) and will be held from Mar 17 - 19, 2020 at SQUARE Brussels Convention Centre, Brussels, Belgium. This Conference covers 9 topics designed to advance healthcare outcomes through innovation across 9 thought leadership streams. Additional details will be posted as soon as they are available.